GlassScriptPhysician profile
John G Cargill
NPI 1144268939
$1,691.44
in general payments reported to CMS, 2019-2025
21 companies · $42.35 in 2025
The $42.35 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $255 · 2021: $279 · 2022: $420 · 2023: $283 · 2024: $125 · 2025: $42.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $450.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $471.07 | 2019-2024 | Lupron Depot |
| Pfizer INC. | $237.50 | 2019-2022 | |
| Astellas Pharma US INC | $128.24 | 2019-2025 | Myrbetriq, Xtandi |
| Medtronic, INC. | $108.79 | 2022-2023 | Interstim |
| Endo Pharmaceuticals INC. | $100.89 | 2021-2024 | Xiaflex, Aveed |
| Boston Scientific Corporation | $75.45 | 2019-2023 | Lithovue |
| Coloplast Corp | $72.84 | 2020-2024 | |
| Endo USA, INC. | $67.77 | 2024 | Xiaflex |
| Bayer Healthcare Pharmaceuticals INC. | $66.57 | 2019-2023 | |
| Travere Therapeutics, INC. | $56.54 | 2020-2021 | |
| Sumitomo Pharma America, INC. | $49.31 | 2023-2025 | Gemtesa |
| Janssen Biotech, INC. | $47.44 | 2022-2023 | Erleada |
| Teleflex LLC | $33.99 | 2021 | |
| Urogen Pharma, INC. | $29.59 | 2020 | |
| Srs Medical Systems, INC. | $29.27 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $27.31 | 2022 | |
| Merck Sharp & Dohme LLC | $26.56 | 2023 | Keytruda, Lynparza |
| Ambu INC. | $16.53 | 2020 | |
| Medtronic USA, INC. | $15.82 | 2020 | |
| Palette Life Sciences, INC. | $15.58 | 2023 | |
| Urovant Sciences INC | $14.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cargill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.